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Abstract. One of the typical features of tuberculosis (TB) is that the infectious agent has 
evolved a symbiotic relationship with the human host; only a relatively small proportion 
of those who are infected go on to develop the clinical disease. Most people are assumed 
to mount an effective immune response to the initial infection that limits proliferation of 
the bacilli, and may lead to long-lasting partial immunity both to further infection and to 
reactivation of latent bacilli remaining from the original infection. The risk of disease is 
believed to be at its highest shortly after infection, to decline thereafter, and to increase 
with age. Often models have divided the routes of progression towards the next stage of 
a disease by assuming that a fixed proportion of those who become infected-per unit of 
time-belongs to the 'slow'· class while the remaining fixed proportion belongs to the 'fast' 
class. This assumption, while appealing, it is restrictive and unnecessary. In this article, 
we formulate a TB model with a distributed delay in the latent period and look at the 
effects of long and variable (rather than exponentially distributed) periods of latency on 
the dynamics of TB. 
Key wards: Tuberculosis -Distributed Delay-Endogenous Infection-Dynamical Systems-
Epidemiology-Communicable Diseases 
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Introduction 
Many mathematical models have been developed to study communicable diseases such 
as measles, influenza, rubella, and chicken pox (see Hethcote 1976, Dietz 1979, Hethcote, 
Stech, and van den Driescsche 1981, Anderson 1982, Anderson and May 1982, 1991, Dietz 
and Schenzle 1985, Dietz 1985, Anderson and May 1983, Schenzle 1984, Hethcote and Van 
Ark 1987, Castilla-Chavez et al. 1988, 1989, Feng 1994, Feng and Thieme 1995). These 
infectious diseases have several features in common; for example, they cause recurrent epi-
demic outbreaks, and transmission rates depend strongly on age-dependent contact rates. 
The etiological agents of these communicable diseases are viruses from different families 
but all are capable of generating similar epidemiological responses (symptoms) at the level 
of the individual. Common responses include relatively short latent periods, followed by 
also relatively short infectious periods and permanent immunity after recovery. It is not 
completely clear when individuals become infectious (that is, _capable of transmitting the 
disease) as some may become infectious while symptomless. The situation of tubercu-
losis (TB), despite its fundamental role in the development of bacteriology and modern 
epidemiology, is different than the situation observed in "childhood" diseases. 
A bacterial disease caused by Mycobacterium tuberculosis, TB is one of the oldest 
human diseases. Evidence that supports human cases of TB as well as its role in human 
mortality exists and goes back for thousands of years (petrified bones from 8,000 B.C.; 
Hindu texts from 2,000 B.C.; and mummy reliquiae from Egypt and pre-Columbian Amer-
ica, including an Incan child from 700 A.D.). TB or TB-associated symptoms appear to 
have been the source of inspiration for Frascatorius' theory of contagion (18th century). 
However, a search for a cause without a clear understanding of the sources and nature of 
disease naturally led to what Ayvazain (1993) calls "centuries of nonscientific chaos." TB 
was so devastating that it became the dominant force in the development of the fields of 
bacteriology, modern epidemiology, and public health. 
The situation changed when Villeman (19th century) used animal models to establish 
that TB is a specific infection due to an innoculable agent (Reichman and Hershfield 
1993). On March 29, 1882, Robert Koch presented to the Berlin Physiologic Society the 
results of his research on the causes of disease. Koch's fundamental research identified 
the mechanisms for disease transmission and the agents responsible for several diseases, 
including the etiological agent of TB (Reichman and Hershfield 1993). Koch's research 
opened new doors and eventually led to the discovery, by various investigators, of other 
bacteriological disease agents including the bacilli for typhoid and diphteria. 
Today, with an estimated 8 to 10 million new cases and 3 million deaths yearly (Koehl 
1991), TB remains the leading cause of death by an infectious disease. Approximately a 
third of the world's population carries Mycobacterium tuberculosis (Miller 1993). Dra-
matic increases in the incidence of TB have also occurred within the United States over 
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the past few years. From 1985 to 1991, the number of reported cases of TB has increased 
18% with 26,283 cases reported in 1991 (Kent 1993). It is predicted that the worldwide 
situation concerning TB will deteriorate rapidly; during this decade, nearly 90 million new 
cases will occur and 30 million people will die from TB unless aggressive intervention is 
undertaken soon (Snider et al. 1994). 
The disease is most commonly transmitted from a person suffering from infectious 
tuberculosis to other persons by infected droplets created when the person with active TB 
coughs or sneezes. One of the differences between TB and childhood diseases is that the 
infectious agent has evolved a better symbiotic relationship with the human host, and a 
relatively small proportion of those infected go on to develop clinical disease (Smith and 
Moss 1994). Data from a variety of sources suggest that the life-time risk of developing 
clinically-evident TB after being infected is approximately 10%, with a 90% likelihood of 
the infection remaining latent (Hopewell1994). Individuals who have latent infection are 
not clinically ill or capable of transmitting TB (Miller 1993). As people age, immunity may 
wane, and the risk of developing active TB as a consequence of either exogenous reinfection 
(i.e., acquiring a new infection from another infectious individual) or endogenous reacti-
vation of latent bacilli (i.e., reactivation of a preexisting dormant infection) may increase 
(Styblo 1991, Smith and Moss 1994). The ability of the organism to survive in a latent 
state and then reactivate many years after the original infection indicates that the tubercle 
bacillus has enjoyed a long period of coevolution with the human host, a period that has 
enabled the bacillus to survive in small population groups for long periods of time. 
The annual risk of developing tuberculosis in individuals previously infected with M. 
tuberculosis who have survived the initial and higher risk period that follows infection 
changes with the age of the individual. The following annual risks have been estimated: 1) 
for children, aged 1- 6, the risk of progression is estimated to be around 0.001648 while for 
those in the 7-12 age range, the risk is about 0.000770 (Comstook et al. 1974); 2) for adults 
in the 15-34 age range, the reported risk of progression is between 0.0008-0.0009, while for 
adults who are over 55 years of age, the risk is reported to be around 0.0010 (Comstock 
and Edwards 1975). The factors that influence whether or not an infected person will 
develop tuberculosis must be highly dependent on an individual's immune system. The 
immune mechanisms of protection against tuberculosis infection are not well known. It 
is believed that cell-mediated immunity is beneficial but that delayed hypersensitivity 
is detrimental for the control of TB infection (Dunlap and Briles 1993). The balance 
between these two related processes must vary among individuals and this balance may 
be genetically determined (Dunlap and Briles 1993, Sifford and Bates 1991). This balance 
could be related to the responses of Mononuclear phagocytes (MPs) and T cells to M. 
Tuberculosis. MPs are responsible for killing and/or inhibiting bacterial pathogenesis 
while T -cells are responsible for the induced immune protection. MPs are the preferred 
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host cells of Mycobacterium tuberculosis while the T-cells seem to enhance pathogen's 
survival. It is suspected that a coordinated interaction between T-cells and MPs plays 
a key role in the ability of an individual's immune system to acquire some amount of 
resistance against tuberculosis-enough to keep the Mycobacterium tuberculosis latent 
for long periods of time. Full protection obviously does not always take place as many 
individuals remain latently infected and, therefore, likely to develop active TB. It has been 
proposed that an imbalance in the immune systems-such as the one described above-is 
behind the 'erratic' activation of clinical disease (Chan and Kaufman 1994). 
The effects of concurrent infections, the presence of alternative diseases, or the use 
of medications that reduce cellular immunity may accelerate TB reactivation. Dutt and 
Stead (1993) have listed many factors that could facilitate TB reactivation in the elderly: 
They include: insulin-dependent diabetes, poor nutrition, long-term corticosteroid therapy, 
other debilitating diseases, smoking, alcohol abuse, and declining cell-mediated immunity. 
It is know that reactivation of latent tuberculosis is important among lllV-infected (i.e. 
Selwyn et al. 1991). TB reactivation is also possible in transplant recipients as a results 
of the use of immunosuppressive agents (Miller et al. 1995). Endogenous reactivation is 
very common in inner cities like in the Bronx, where 62 % of TB incidence cases have been 
associated with individuals who have latent TB (Alland et al. 1994). Diabetic persons 
progress from tuberculin positive status to active tuberculosis more often than non diabetic 
ones (Boucot et al. 1952, Warwick 1957, Oscarrson and Silwer 1958, Opshal et al. 1961, 
Henri and Benett 1985). 
Additional evidence related to genetic factors associated with the reactivation of TB 
endogeneous infection has been suggested (Chan and Kaufman 1994). Some studies suggest 
the possibility of selection playing a role in host resistance in the Qu'appelle Valley Indian 
Reservation in Canada (Goodman and Motulsky 1979). It is also known that the BCG 
gene (candidate Nramp) confers resistance against mycobacteria in mice. BCG acts at 
the macrophage level and it is thought to control some aspect of macrophage priming for 
activation (Skamme 1986, Chan and Kaufmann 1994, Brown et al. 1995). 
This paper is organized as follows: Section 1 introduces a distributed delay TB model. 
In Section 2 we compute its basic reproductive number and study its role in the dynamics 
and stability properties of this model. Section 3 details some of our current efforts and 
extensions including the incorporation of re-infection and the effects of age-dependent 
contact rates. An appendix collects some of the mathematical details. 
1. A TB model with distributed delay 
We divide the host population into the following epidemiological classes or subgroups: 
susceptibles (S), exposed (E, infected but not infectious), infectious (I, assumed infec-
tious), and effectively treated (T) individuals. N denotes the total population. Our previ-
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ous paper (Castilla-Chavez and Feng 1996) introduced a simple model for the transmission 
ofTB: 
d I 
-8 = A - f3c8- - p,S 
dt N 
d I I 
-E = f3c8-- (JL + k)E + af3cT-dt N N 
d 
dt I = kE - (JL + r + d) I 
d I 
-T = ri- af3cT-- p,T 
dt N 
N=S+E+I+T. 
A is the constant recruitment rate, f3 and af3 are the average numbers of susceptible 
and treated individuals infected by one infectious individual per contact per unit of time, 
0 :::; a :::; 1, c is the per-capita contact rate, JL is the per-capita natural death rate, d is 
the per-capita disease-induced death rate, r is the per-capita treatment rate. We assumed 
that an individual can be infected only by contacting infectious individuals. 
We modify the above model by assuming a variable removal rate (instead of an expo-
nentially distributed latency period) from the E class to the I class. Let p( s) be a function 
representing the proportion of those individuals exposed at timet and who, if alive, are 
still infected (but not infectious) at time t + s. Assume that 
p(s) ;:::: O,p(s) :::; O,p(O) = 1, 
and 100 p(s)ds < oo. 
Then the number of individuals who have been exposed from time 0 to t and are still in 
class E is given by 
1t f3c[S(s) + aT(s)] ~~s;)p(t- s)e-p.(t-s)ds, 
where -p( -r) is the rate of removal of individuals from E class into I class -r units of time 
after exposed, the number of individuals who become infectious from time 0 to t and are 
still alive and in I class is 
(1.1) r {r f3c[S(s) + aT(s)] I(s) e-p.(r-s)[-p(-r- s)e-(1-'+r-td)(t-r)]dsd-r. Jo Jo N(s) 
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Then we have the following model: 
d I 
dt S = A - (3cS N - p,S 
E(t) = Eo(t) + 1t f3c[S(s) + o-T(s)] ~~s;)p(t- s)e-J.L(t-8 )ds 
(1.2) I(t) = ( { 7 f3c[S(s) + o-T(s)] J(s) e-J.L(-r-8 )[-p(r- s)e-(J.L+r+d)(t--r)Jdsdr lo Jo N(s) 
+ foe -(J.L+r+d)t + Io ( t) 
d I 
dtT = ri- o-(3cT N- pT 
N=S+E+I+T, 
where E0 (t) denotes those individuals in E class at timet= 0 and still in the latent class, 
Io(t) denotes those initially in class E who have moved into class I and are still alive at 
timet, and J0 e-(J.L+r+d)t with 10 = 1(0) represents those who are infectious at time 0 and 
are still alive and in the I class. E0 (t) and J0 (t) are assumed to have compact support 
(that is they vanish for large enough t). 
The I equation in (1.2) is a Volterra integral equation if we change the order of 
integrations as the following : 
and notice that 
(1.3) r-8 
= -e-(J.L+r+d)(t-s) Jo p( u)e(r+d)udu 
=: a(t- s). 
Therefore we can rewrite the I equation in (1.2) as 
(1.4) I(t) = 1t a(t- s)f3c[S(s) + o-T(s)] ~~s;) ds + I0e-(J.L+r+d)t + I0 (t). 
Results on well-posedness found in Miller (1971) guarantee the existence and uniqueness 
of solutions as well as their continuous dependence on parameters for System (1.2) as a 
system of nonlinear integral equations. 
The positivity of solutions can be proved similarly to Castilla-Chavez et al. (1989). 
2. Equilibrium points and their stabilities 
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In this section we assume that the probability of being infected for a treated individual 
is the same as for a susceptible individual, i.e., CT = 1. Let 
I 
W=S+T, B=,BcW N. 
Then System (1.2) with the I equation replaced by (1.4) becomes 
(2.1) 
(2.2) 
d 
-W=A-B-JLW dt 
E_(t) = Eo(t) + 1t B(s)p(t- s)e-!1-(t-s)ds 
. t 
I(t) = Ioe-(Jl-+r+d)t +Io(t) + 1 a(t- s)B(s)ds 
I(t) 
B(t) = ,BcW(t) N(t). 
The basic reproductive number in this case is given by 
where 
and a(u) is given by (1.3). 
Let 
DE= 1 00 p(s)e-P.8 ds, 
then DE is the death-adjusted mean length of the latent period. The relation between Dr 
and DE is given by 
(2.3) 
Remark: in the case of an exponentially distributed latent period with a mean length 
1/k we have p(t) = e-kt, and the formulae (2.2) and (2.3) give 
'RD = ,BcDr = ( (3c )(-k-). 
JL+r+d k+JL 
System (2.1) with Eo(t) = Io(t) = Io = 0 always has the disease-free equilibrium 
A (Wo, Eo,lo) = ( -, 0, 0), 
JL 
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and has no other constant solution. Since Eo(t) and J0 (t) are zero for large t, and 
e-(J.L+r+d)t --+ 0 as t--+ oo, it could be expected that (A/ J-L, 0, 0,) is an asymptotic equilibrium 
of (2.1) as t--+ oo. This is shown by the following theorem. 
Theorem 1. IfRo:::; 1, then the disease-free equilibrium ( *' 0, 0) of the system (2.1) is a 
global attractor, i.e., limt_.00 (W(t), E(t), I(t)) --+ ( !!., 0, 0) for any positive solutions of the J.L . 
system (2.1). 
The proof can be found in Appendix A. 
The following result shows that when Ro > 1, the disease will persist in the population. 
Theorem 2. If Ro > 1, then the disease-free equilibrium of System (2.1) is unstable. 
Furthermore, there exists a constant 1J > 0, such that any solution (W(t), E(t), I(t)) of 
(2.1) with I(O) > 0 satisfies 
limsupJ(t) ~ rJ. 
t->oo 
Theorem 2 is proved in Appendix B. 
According to Miller (1971), an endemic equilibrium of the system (2.1), if it exists, 
must satisfy the limiting system associated with (2.1), which is given by the following set 
of equations: 
(2.4) 
d 
-W=A-B-J-LW+rl dt 
E(t) = ltoo B(s)p(t- s)e-J.L(t-s)ds 
I(t) = ltoo a(t- s)B(s)ds 
I(t) 
B(t) = ,BcW(t) N(t). 
Let (W*, E*, I*) be a constant solution of (2.4) with I* > 0, and let B* = ,BcW* J: .. Then 
I*= B* (1: a(t- s)ds + 1t a(t- s)ds) 
(2.5) 
= B* (100 a(T)dT + 1t a(T)dT) 
= B*Dr. 
Similarly we can get 
(2.6) E* = B*DE. 
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Then by (2.5) we get 
(2.7) ~* 1 1 N* = f3cDr = Ro · 
Using (2.6), (2.7) and~*+ E* +I*= N* we get 
(2.8) 
Note that 
(2.9) 
I* _ (1 1 ) Dr 
N*- - ~ Dr+DE' 
E* _ (1 _ _!_) DE 
N*- ~ Dr+DE 
A= B* + p,~*- rl*. 
Dividing both sides of (2.9) by N* and using (2.7), (2.8) we get 
(2.10) N*- A~ 
- J.£ + (~ _ 1) 1-rDr · 
Dr+ DE 
Note that r Dr < (p, + r + d)Dr = 1- p,DE ~ 1, hence N* > 0 if~ > 1. It is easy to see 
from (2.8) that only when Ro > 1 the unique endemic equilibrium exists and is given by 
(2.11) 
where N* is given by (2.10). The stability of the endemic equilibrium is given in the 
following result. 
Theorem 3. If 'Ro > 1, then the limiting system (2.4) has a unique endemic 
equilibrium which is locally asymptotically stable. 
We give the proof of Theorem 3 in Appendix C. 
3. Discussion 
In this paper we have constructed a TB model with a distributed delay to study the 
effect of variable periods of latency on the transmission dynamics of TB at the population 
level. These long and variable periods of latency were not considered in our previous paper 
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(see Castilla-Chavez and Feng 1996) as our emphasis there was on the study of resistant 
TB. The purpose of this paper is to look at the effects of variable (rather than exponentially 
distributed) periods of latency on the dynamics of TB. 
We found that the qualitative dynamics of TB predicted by this model are no different 
from those given by our basic TB model with an exponentially distributed latency period 
(Castilla-Chavez and Feng 1996). The disease either dies out or remains endemic regardless 
of the shape of the incubation/latent period distribution. Blower et al. (1995) have 
developed a differential equation model with 'two' latent groups: one group involves those 
who will develop tuberculosis quickly after primary infection while a second group is formed 
of those who will develop disease slowly through endogenous reactivation. Since there is 
only one group of susceptible in their model, the 'two-group' effect is achieved by assuming 
that some fixed proportion of those who become infected (per unit of time) follows the 
fast route while the remaining proportion follows the slow route. The result~ of the model 
in this article show that this artificial division is not necessary and it plays no role in the 
qualitative dynamics. Furthermore, the division may cause confusion as it is not clear from 
their (Blower et al.) model how this fixed fraction could be selected in an epidemiologically 
or sociologically meaningful way. The fixed fraction model (referred to in Blower et. al. 
1995) actually depends on factors that are not part of Blower et al.'s model and/or the 
model in this article (e.g. the age of the infected person). Age is a relevant factor, but it 
cannot J·ust be assumed a priori that a fixed proportion of individuals in a particular age 
bracket develop active TB. Contact rates-conducive to TB transmission-are very likely to 
be age-dependent and the mixing between age-classes is nonlinear. Therefore, to study 
the dynamics of 'fast' versus 'slow' TB one must really use an age-structured model. The 
analysis of age-structured models, while complex, is not impossible (see Castilla-Chavez 
and Feng 1996a). Blower et al. (1995) compute Ro but study the dynamics of their model 
exclusively through simulations which turn out to be 'typical'. Our analytical results have 
confirmed their limited simulations not only for the 'slow /fast' TB model but also for 
models where individuals progress towards active TB at 'all' possible rates. The fact that 
long and variable periods of 'latency' do not lead to complex dynamics has been worked 
out before. For example, Castilla-Chavez et al. (1989a, b, c) established that long and 
variable periods of infection for the transmission dynamics of mv I AIDS have the same 
qualitative behavior as the dynamics of models with unrealistic exponentially distributed 
latent/infectious periods. However, factors such as exogenous infection and heterogeneous 
contact rates can indeed generate radically different dynamics than those given by the 
class of models discussed in this article. Exogenous reinfection is capable of sustaining TB 
even when the basic reproductive number Ro < 1 (see Castilla-Chavez and Feng 1996b). 
Computation of the reproductive number in this article helps understand the role that 
key epidemiological parameters play in the maintenance of TB-including the role of the 
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parameters associated with an arbitrary distribution that models long and variable periods 
of latency. 
To summarize our perspective: a person infected with TB may develop active TB 
in a variety of ways. One possibility is that a person may develop active TB as a result 
of an endogenous infection-the subject of this article. In this case, there is no impact 
on the qualitative dynamics of the transmission dynamics of TB. A second possibility is 
that such a person may develop active TB as a consequence of exogenous reinfection (i.e., 
acquiring a new infection from another infectious individual; Smith 1993). Our results 
show that exogenous reinfection can have a drastic effect on the qualitative dynamics 
of TB (see Castilla-Chavez, Feng and Capurro 1996). The incorporation of exogenous 
reinfection into the basic TB model of Section 1 allows for the possibility of a subcritical 
bifurcation. Thus, a "backwards" bifurcation of an endemic equilibrium may occur at 
the critical value of the reproductive number no = 1 and hence, our system can have 
multiple endemic equilibria for no < 1. This type of behavior has been observed in recent 
epidemiological models in the context of sexually-transmitted diseases (see Hadeler and 
Castilla-Chavez 1995). Mixing plays a key role in TB transmission. We are particularly 
interested in looking at the effects of age-dependent contact rates on TB dynamics as well 
as contact rates that are dependent on the place of activity (the role of household contact 
rates versus the role of contact rates experienced by users of public transportation). The 
formulation of models with age-dependent contact rates (or other heterogeneous contact 
rates) even under the assumption of proportionate mixing, leads to hyperbolic systems 
of partial differential equations that are difficult to analyze (b~t see Castilla-Chavez and 
Feng 1996a). Nevertheless, preliminary results are possible and we plan to use them to 
study not only the role of endogenous infection but also the effectiveness of TB vaccines 
(such as the BCG vaccine) on the dynamics of TB within age-structured populations. 
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Appendix A: The global stability of the disease-free equilibrium 
For a bounded real-valued function f on (0, oo) we define 
!oo = liminfj(t), rX> =lim sup j(t). 
t->oo t->oo 
Lemma 1 (Thieme 1993) Let f : (0, oo) ~ R be bounded and twice diHerentiable with 
bounded second derivative. Let tn ~ oo and f(tn) converge to j 00 or foo for n ~ oo. Then 
J'(tn) ~ 0, n ~ 00. 
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The proof of Theorem 1: 
Let RD < 1. Differentiating the E and I equations in (2.1) and using the fact that 
E0(t), I0 (t) have compact supports, we get 
(A1) d t dt E = B + Jo B(s)p(t- s)e-p.(t-s)ds- p,E, 
and 
(A2) d 1t -1 = -(p, + r + d)I- B(s)p(t- s)e-p.(t-s)ds- (p, + r + d)I0e-(p.+r+d)t dt 0 
for large t. Then 
(A3) d dt N = A - p,N - dl- (p, + r + d)Ioe-(p.+r+d)t. 
Noticing that 
and using Lemma 1 we get 
~<N: <Noo<A. p,+d- oo_ -p, 
Hence we can assume, without loss of generality, that A/ p, + d::::; N(t) ::::; (A/ p,) fort~ 0. 
Claim that ] 00 = 0. 
Suppose ] 00 > 0. Note that -p(t) ~ 0 and 
(A4) 
By (A4), Lemma 1 and the fti equation (A2), we can choose a sequence tn -+ oo such 
that 
d 
dtl(tn)-+ 0, as I(tn) -t 100 , 
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and 
(A5) 
N - E - JOO r)() 
0 :S; -(JL + r + d)100 +,Be( N Y10 100 Jo -p(r)e-JL(r)dr 
:S; -(JL + r + d)J00 + ,8c(1- ~ J0°)J00(l- JLDE)· 
Note that ] 00 > 0 and 
(A6) 
Then (A5) gives 
JOO < A(1- ___!__) 
-JL 'Ro' 
indicating that ] 00 :S; 0 since~ < 1. This contradicts 100 > 0. 
Note that for any positive solution of (2.1) 100 ~ 0. It follows that ] 00 = ] 00 = 0, 
hence 
(A7) lim J(t) = 0. 
t-->00 
Note that 
B 00 :S; ,BcW00 ~: = 0. 
By Lemma 1 and the !E equation (A1), we can choose Sn -t. oo such that ftE(sn) -t 
0, E(sn) -t E 00 , and 0 :S; -JLE00 • This implies that E 00 = 0, i.e., 
(A8) lim E(t) -t 0. 
t-->00 
Similarly, using Lemma 1 and the ftW equation in (2.1), we have 0 ~A- J.LW00 • Hence 
W 00 ~ A/ JL. But woo :S; A/ JL, hence W 00 = woo = A/ JL, i.e., 
(A9) lim W(t) =A_ 
t-->oo J.L 
>From (A7), (A8), and (A9) we have 
lim(W(t), E(t),I(t)) -t (A, 0, 0), t -too 
J.L 
for all positive solution of (2.1). 
Appendix B: Stability and instability for the system (2.1) 
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Lemma 2. If no > 1, then any solution (W(t), E(t), I(t)) of (2.1) with 1(0) > 0 satisfies 
limsupJ(t) > 0. 
t--+oo 
Proof: Since J0(t) has compact support, we can replace the I equation in (1.5) by 
(BO) I(t) = 10e-(11.+r+d)t + 1t a(t- s)B(s)ds. 
Suppose that the conclusion of the Lemma is not true. Then 100 ;= 0, or limt--+oo I(t) = 0. 
This also implies that (see the proof of Theorem 1) limt--+oo E(t) = 0. It follows that 
limt--+oo W(t)/N(t) = 1. Hence there is a sequence {kn} > 0 such that kn -t oo as n -t oo, 
and 
(B1) W(t) 1 N(t) > 1- ;' for all t 2: kn. 
Note by (A2), that :ftl(t) -t 0 as t -t oo. Whenever I(t) gets close to 0 for large t it 
will stay close to 0 for a long time. Also noticing that 1(0) > o· and ] 00 = 0, we can find 
sequences Bn, tn such that tn- Bn -too, Bn -too and 
(B2) 
Then by (BO), (B1), and (B2), after choosing a subsequence, we get 
(B3) 
{tn I(s) 
I(tn) = Ioe-{IL+r+d)t,. + Jo . a(tn- s),BcW(s) N(s) ds 
1 1tn > ,8c(1-- )I(tn) a(tn- s)ds. 
n Bn 
Note that I(tn) > 0 for all nand 
(B4) 1t,. 1t,.-Bn a(tn- s)ds = a(r)dr -t Dr, 
n 0 
n -too. 
Then by (B3) and (B4), dividing both sides of (B3) by I(tn) and taking n -too, we get 
1 > ,BcDr = no. 
But no > 1, a contradiction. 
The proof of Theorem 2: 
14 
Using Lemma 1, by (A4) and the 1tE equation (A1) we have 
I I 
0:::; jJc(W N)oo + jJc(W N)oo(J-LDE- 1)- p,E00 
I 
< jJc(W N)00 (1 + p,DE)- p,E00 
:::; jJci00 (1 + p,DE)- p,E00 , 
or 
(B5) 
Similarly by the !I equation in (A2) and Lemma 1 we·have 
(B6) 
w 
0 2 fJc( N )00100(1- p,DE)- (p, + r + d)I00 
E+I 2 /Jc[1- ( J:r )00] (1- p,DE)100 - (p, + r + d)l00 • 
Since ]00 > 0 by Lemma 2, (B6) yields 
(B7) 
On the other hand, from (B5) we can get 
(B8) 
Let 
(1- ..!..)..lL 
'R.o p,+d 
7]= 1+~(1+p,DE)' 
then 7J > 0 since Ro > 1. By (B7) and (B8) we get 
Appendix C: Asymptotic stability of the endemic equilibrium 
The proof of this result reduces to the study of the local stability of the trivial equi-
librium (X= 0) for a Volterra integral equation of the type 
(C1) X(t) = F(t) + 1t A(t- s)G(X(s))ds, 
15 
where X E Rn,G(O) = O,G E 0 1(Rn ----t Rn),F E O([O,oo) ----t Rn), A is ann x n matrix 
such that A(t) E L1[0, t] for each t > 0. Rn denotes real n-space with a norm lXI, and IAI 
denotes the corresponding matrix norm. 
Theorem (Miller 1968; Theorem 4). Assume that the following conditions hold: 
{i) the Jacobian matrix DG(O) is nonsingular, 
{ii) det (In- J000 e->.r A(T)DG(O)dT) =/= 0, for all>. with 3U 2: 0, where In denotes 
the n x n identity matrix, and 
{iii) there is a sufficiently small Eo > 0 such that {sup IF( t) I; 0 ~ t < oo} ~ Eo and 
F(t) ----t 0 as t ----t oo. 
Then X ( t) ----t 0 as t ----t oo. 
Proof of Theorem 3: 
First we rewrite theW equation in (2.4) as 
(02) A A 1t W(t) = - + (W(O)-- )e-Jlt + (ri(s)- B(s))e-Jl.(t-s)ds. 
p p 0 
Noticing that 
(03) 
we can then write theE equation in (2.4) as 
E(t) = 1t B(s)p(t- s)e-Jl.(t-s)ds 
= ft [A+ ri(t)- e-Jl.t.!!_ (W(t)eJi.t)]p(t- s)e-Jl.(t-s)ds Jo dt 
=A 1t p(T)e-Jl.r dT + r 1t I(s)p(t- s)e-Jl.(t-s)ds 
- r .!!_(W(s)eJ1.8 )p(t- s)e-Jl.tds Jo dt 
(04) 
=A 1t p(T)e-Jl.r dT + r 1t I(s)p(t- s)e-Jl.(t-s)ds 
- W(t) + W(O)p(t)e-Jl.t- 1t W(s)p(t- s)e-Jl.(t-s)ds. 
We next transform System (2.4) to the origin by letting 
w = w- W*' E = E - E*' j = I- I*. 
Let 
(05) A I(t) A * i(t) +I* B(t) = ,BcW(t) N( ) = ,Bc(W(t) + W ) A , 
t N(t)+N* 
16 
where 
N* = W* + E* +I*' N(t) = W(t) + E(t) + i(t). 
Then noticing that 
(C6) 
and by (C2)- (C6), we have 
W(t) = W(O)e-JLt + r it i(s)e-JL(t-s)ds- it (B(s)- B*)e-JL(t-s)ds, 
E(t) = W(O) (p(t) - l)e-JLt + 1: (B(s)- B*)p(t- s)e-JL(t-s)ds 
(C7) + r it i(s) (p(t- s)- l)e-JL(t-s)ds +it (B(s)- B*)e-JL(t-s)ds 
- 1t W(s)p(t- s)e-JL(t-s)ds, 
i(t) = 1: (B(s)- B*)a(t- s)ds +it (B(s)- B*)a(t- s)ds. 
Then System ( C7) is in the form ( Cl ). with 
( 
W(O)e-JLt ) 
(C8) F(t) = W(O) (p(t) -/)e-:: + f~oo (B(s)- B*)e-JL(t-s)ds , 
Loo (B(s) - B*)a(t- s)ds 
( ClO) G(X) ~ ( iJ ~ B' ) , 
(Cll) X~ (1) 
It remains to show that the conditions specified in Miller's theorem are satisfied. To 
simplify expressions, let 
W* 
x=-N*' 
E* I* 
y = N*' z = N*. 
17 
Note that 
(C12) DG(O) = ( ,Bcz(~ + z) -.B:z ,Bcx(~ + y)) . 
Then det DG(O) = -f3cxz =I= 0 since X > 0, z > 0 when no > 1. The condition (i) is 
satisfied. 
Next we check the condition (ii). Note by (09) and (012) that 
where 
(C13) m1 = f3cx(x + y), m2 = f3cxz, ma = f3cz(y + z). 
Then 
H(:A) = det (In -100 e-.\r A(r)DG(O)dr) 
( 
1 + Jl~3.\ 
= fooo p( T )e-(p.H)r dr - ll~3.\ 
-ma J000 a(r)e-.\r dr 
After canceling terms we get 
(C14) 
ma m2 
H(.\) = 1 + JL +:A + JL +:A 
- (ml + rmaJ roo a(r)e-.\r dr 
JL+" Jo 
+ ~ roo p(r)e-(p.+.\)r dr. 
JL + .\ Jo 
It is easier to estimate IH(A.)I if we express ftp(r)e-(Jl.+.\)rdr in terms of J000 a(r)e-.\rdr. 
Using the definition of a(t) (see L3) we have 
(C15) 100 p(r)e-(Jl.+.\)r dr = -(JL + r + d +A.) 100 a(r)e-.\r dr. 
Then (014) and (015) yield 
IH(.X)I ~ ll + ma' + m2' I 
JL+A JL+A 
( rma m2(r +d)) 100 .x 
-I m1 + ffi2 + --, + A a(r)e- r drl. 
JL+A JL+ 0 
{C16) 
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Since~).~ 0, we have Jt !a(r)e-krldr ~Dr. Note that 
W* 1 
x=-=-
N* no' 
(G17) f3cDr =no, 
(m1 + mz)Dr = f3cx(x + y + z)Dr = 1, 
r Dr ~ (r + d)Dr < (p. + r + d)DI = 1- DE < 1. 
Then by (C15)- (C17) we can show that 
IH(.A)I ~ 11 + ma' + mz' I /£+A /£+A 
ma , mz 
-l(ml + mz)Dr + --, rD1 + --, (r + d)Drl /£+A /£+A 
> 0, 
whenever ~). ~ 0. 
Furthermore, clearly for any eo > 0, there is a 8o > 0 such that {sup IF(t)l : 0 < 
t < oo} ~eo and F(t) ~ 0 as t ~ oo, for any IW(r)l ~ 8o, IE(r)l ~ 8o, li(r)l < 8o, and 
-oo < r ~ 0. 
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